James H Mackaness insider trades: Soleno Therapeutics (SLNO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
37 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | SLNO | ↓ Sell | 90,622 | $69.44 | $6.3M | Direct | Mar 31, 2025 (4d) |
| Jan 3, 2025 | SLNO | ↓ Sell | 7,874 | $45.78 | $360K | Direct | Jan 6, 2025 (3d) |
| Oct 1, 2024 | SLNO | ↓ Sell | 8,077 | $49.43 | $399K | Direct | Oct 3, 2024 (2d) |
| Aug 29, 2024 | SLNO | ↓ Sell | 13,531 | $47.43 | $642K | Direct | Aug 30, 2024 (1d) |
| Aug 6, 2024 | SLNO | ↓ Sell | 14,983 | $45.60 | $683K | Direct | Aug 7, 2024 (1d) |
| Jul 1, 2024 | SLNO | ↓ Sell | 7,190 | $41.54 | $299K | Direct | Jul 3, 2024 (2d) |
| Apr 1, 2024 | SLNO | ↓ Sell | 5,175 | $41.34 | $214K | Direct | Apr 3, 2024 (2d) |
| Dec 11, 2023 | SLNO | ↓ Sell | 32,482 | $36.41 | $1.2M | Direct | Dec 13, 2023 (2d) |
| Nov 30, 2023 | SLNO | ↓ Sell | 4,186 | $28.65 | $120K | Direct | Dec 4, 2023 (4d) |
| Nov 29, 2023 | SLNO | ↓ Sell | 8,081 | $27.49 | $222K | Direct | Nov 30, 2023 (1d) |
| Sep 13, 2021 | SLNO | ↑ Buy | 11,235 | $0.89 | $10K | Direct | Sep 14, 2021 (1d) |
| Jun 26, 2020 | SLNO | ↑ Buy | 6,060 | $1.65 | $10K | Direct | Sep 14, 2021 (445d) |
| Mar 16, 2018 | IVTY | ↑ Buy | 2,528 | $3.90 | $10K | Direct | Mar 19, 2018 (3d) |
| Nov 8, 2016 | IVTY | ↑ Buy | 1,700 | $5.75 | $10K | Direct | Nov 9, 2016 (1d) |
| May 18, 2016 | IVTY | ↑ Buy | 2,000 | $5.08 | $10K | Direct | May 19, 2016 (1d) |
| Aug 19, 2015 | IRIX | ↓ Sell | 2,373 | $7.15 | $17K | Direct | Aug 21, 2015 (2d) |
| Aug 18, 2015 | IRIX | ↓ Sell | 2,627 | $7.10 | $19K | Direct | Aug 19, 2015 (1d) |
| Aug 17, 2015 | IRIX | ↓ Sell | 2,235 | $7.05 | $16K | Direct | Aug 19, 2015 (2d) |
| Aug 14, 2015 | IRIX | ↓ Sell | 7,765 | $6.99 | $54K | Direct | Aug 17, 2015 (3d) |
| May 20, 2015 | IRIX | ↓ Sell | 2,000 | $9.80 | $20K | Direct | May 21, 2015 (1d) |
| Jul 21, 2014 | IRIX | ↓ Sell | 1,000 | $7.62 | $8K | Direct | Jul 23, 2014 (2d) |
| Jun 23, 2014 | IRIX | ↓ Sell | 2,000 | $8.24 | $16K | Direct | Jun 24, 2014 (1d) |
| May 21, 2014 | IRIX | ↓ Sell | 3,000 | $8.73 | $26K | Direct | May 22, 2014 (1d) |
| Apr 22, 2014 | IRIX | ↓ Sell | 4,000 | $8.74 | $35K | Direct | Apr 23, 2014 (1d) |
| Mar 21, 2014 | IRIX | ↓ Sell | 4,000 | $9.03 | $36K | Direct | Mar 24, 2014 (3d) |
| Dec 2, 2013 | IRIX | ↓ Sell | 10,000 | $10.52 | $105K | Direct | Dec 3, 2013 (1d) |
| Nov 6, 2013 | IRIX | ↓ Sell | 10,000 | $8.35 | $83K | Direct | Nov 8, 2013 (2d) |
| Jun 18, 2013 | IRIX | ↓ Sell | 19,862 | $4.58 | $91K | Direct | Jun 20, 2013 (2d) |
| Jun 17, 2013 | IRIX | ↓ Sell | 10,568 | $5.38 | $57K | Direct | Jun 18, 2013 (1d) |
| Jun 13, 2013 | IRIX | ↓ Sell | 1,400 | $5.30 | $7K | Direct | Jun 14, 2013 (1d) |
| Jun 11, 2013 | IRIX | ↓ Sell | 1,200 | $5.61 | $7K | Direct | Jun 13, 2013 (2d) |
| Jun 10, 2013 | IRIX | ↓ Sell | 6,970 | $5.36 | $37K | Direct | Jun 12, 2013 (2d) |
| Feb 19, 2013 | IRIX | ↓ Sell | 6,000 | $4.55 | $27K | Direct | Feb 19, 2013 (0d) |
| Feb 14, 2013 | IRIX | ↓ Sell | 9,000 | $4.77 | $43K | Direct | Feb 14, 2013 (0d) |
| Feb 11, 2013 | IRIX | ↓ Sell | 6,000 | $4.61 | $28K | Direct | Feb 11, 2013 (0d) |
| Feb 7, 2013 | IRIX | ↓ Sell | 9,000 | $4.69 | $42K | Direct | Feb 7, 2013 (0d) |
| Mar 13, 2009 | IRIX | ↑ Buy | 2,000 | $0.84 | $2K | Direct | Mar 13, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SLNO insiders
Open-market trades in the last 12 months
About James H Mackaness's insider trades
James H Mackaness is Chief Financial Officer at Soleno Therapeutics (SLNO). Since Mar 13, 2009, James has reported 6 open-market purchases worth $51K and 31 sales worth $11.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (26 filings), grants and awards (18 filings), shares withheld for taxes (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLNO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.